We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current EVOK market cap is 6.24M. The company's latest EPS is USD -5.2436 and P/E is -0.83.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 810k | 1.13M | 1.56M | 1.68M | 1.74M |
| Operating Income | -2.16M | -1.78M | -1.6M | -1.89M | -1.5M |
| Net Income | -2.24M | -1.87M | -1.69M | -1.99M | -1.58M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 23k | 1.62M | 2.51M | 5.18M |
| Operating Income | -7.16M | -13.05M | -8.15M | -7.79M | -7.43M |
| Net Income | -7.13M | -13.16M | -8.54M | -8.22M | -7.79M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 10.04M | 8.98M | 7.85M | 7.07M | 12.45M |
| Total Liabilities | 7.91M | 8.44M | 8.73M | 9.65M | 8.96M |
| Total Equity | 2.13M | 538k | -874k | -2.58M | 3.5M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 6.4M | 9.43M | 10.57M | 11.85M | 7.07M |
| Total Liabilities | 2.02M | 12.65M | 7.02M | 7.77M | 9.65M |
| Total Equity | 4.38M | -3.22M | 3.56M | 4.09M | -2.58M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.63M | -2.84M | -3.88M | -4.99M | -2.58M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | N/A | N/A | -119k | 7.54M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.76M | -6.63M | -12.35M | -6.6M | -4.99M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 6.11M | 9.04M | 13.43M | 7.3M | -119k |
| Market Cap | 6.24M |
| Price to Earnings Ratio | -0.83 |
| Price to Sales Ratio | 1.25 |
| Price to Cash Ratio | 1.37 |
| Price to Book Ratio | -2.51 |
| Dividend Yield | - |
| Shares Outstanding | 1.49M |
| Average Volume (1 week) | 50.36k |
| Average Volume (1 Month) | 1.06M |
| 52 Week Change | -72.00% |
| 52 Week High | 17.40 |
| 52 Week Low | 3.54 |
| Spread (Intraday) | 2.67 (39.79%) |
| Company Name | Evoke Pharma Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.evokepharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
